http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1231494-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06086 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-695 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-695 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-068 |
| filingDate | 1968-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1971-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1231494-A |
| abstract | 1,231,494. ACTH-active peptides. CIBAGEIGY A.G. 9 July, 1968 [12 July, 1967], No. 32616/68. Addition to 1,119,353. Heading C2C. Novel peptides H-D-ser-tyr-ser-met-glu-hisphe - arg - try - gly - lys - pro - val - gly - lyslys - lys - lys - val - NH 2 and H - D - ser - tyrser - nle - glu - his - phe - arg - try - gly - lyspro - val - gly - lys - lys - lys - lys - val - NH 2 and their therapeutically acceptable acid addition salts and complexes are prepared by standard methods of peptide synthesis. The following compounds are isolated as intermediates: N<SP>α</SP> - CBO - lys(BOC) - val- NH 2 ; H - lys(BOC) - val - NH 2 ; CBO - lys(BOC) lys(BOC) - val - NH 2 ; H - lys(BOC) - lys(BOC)- val - NH 2 ; CBO - lys(BOC) - pro - val - glylys(BOC) - lys(BOC) - lys(BOC) - lys(BOC)- val - NH 2 ; H - lys(BOC) - pro - val - gly - lys- (BOC) - lys(BOC) - lys(BOC) - lys(BOC) - val- NH 2 ; and the novel peptides in which the terminal and side chain NH 2 groups and the side chain -COOH group of the glutamic acid residue are protected. Pharmaceutical compositions comprise the peptides of the invention in admixture with a suitable carrier and are formulated for enteral or parenteral administration. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9925263-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10179172-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10646571-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10849977-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9913905-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10821183-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10821184-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11471479-B2 |
| priorityDate | 1964-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.